Berallo, Antonio, .

HRN: 04-06-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
LEVOFLOXACIN 500MG (TAB)
06/20/2025
06/26/2025
PO
500 Mg
OD
Cap Mr
Checking Initial Appropriateness 
06/20/2025
CEFTAZIDIME 1GM (VIAL)
06/20/2025
06/26/2025
IV
1 Gram
Q 8 Hours
Cap Mr
Checking Initial Appropriateness 
07/06/2025
COTRIMOXAZOLE 960MG (TAB)
07/06/2025
07/12/2025
PO
960mgtab
Q8
Cap Mr
Remove - Pending Acceptance
07/09/2025
CEFTAZIDIME 1GM (VIAL)
07/09/2025
07/15/2025
IV
1g
Q24h
T/c Sepsis
Remove - Pending Acceptance
07/09/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/09/2025
07/15/2025
IV
2.25g
Q6h
T/c Sepsis
Remove - Pending Acceptance
07/09/2025
COTRIMOXAZOLE 960MG (TAB)
07/09/2025
07/15/2025
ORAL
960mg
OD
T/c Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: